Teodor Stanescu

α/β for Hepatocellular Carcinoma Tumors Treated with Radiotherapie

The Contribution of Cirrhosis Progression in Liver Dysfunction After Stereotactic Body Radiotherapie

Utility-Based Dose Selection for Stereotactic Body Radiotherapie in Hepatocellular Carcinoma